Clinical Investigation for Everolimus Drug Eluting Stent
NCT06769217
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
888
Enrollment
INDUSTRY
Sponsor class
Conditions
Coronary Arterial Disease (CAD)
Interventions
DEVICE:
Drug Eluting Coronary Stent
Sponsor
Frisch Medical Device Private Limited